Essais cliniques en cancérologie à Bellinzona
66 essais ouverts avec au moins un centre à Bellinzona, d'après ClinicalTrials.gov, mis à jour le 28 octobre 2026.
Ces résultats sont indicatifs et ne remplacent pas un avis médical — à discuter avec votre médecin.
Essais ouverts
- Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%
NCT07020065Recrutement en coursPhase 2
- Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)
NCT07365423Recrutement en coursPhase 2
- Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
NCT04728893Recrutement en coursPhase 2
- MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.
NCT07574047Recrutement en coursPhase 2
- Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion in Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T): a Randomized Trial.
NCT07593482Recrutement en coursPhase 2
- A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
NCT06090539Recrutement en coursPhase 1 · Phase 2
- Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK
NCT06358573Recrutement en coursPhase 2
- A 2-part Phase 1/2 Open-label Trial on ODM-212
NCT07563738Recrutement en coursPhase 1 · Phase 2
- A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
NCT06717347Recrutement en coursPhase 3
- LUCINAE Registry: Thoracic Cancers During Pregnancy
NCT07699861Recrutement en cours
- A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
NCT06428409Recrutement en coursPhase 1 · Phase 2
- Safety and Efficacy of Ruxolitinib in Patients With HNSCC and High NLR Treated With Pembrolizumab - The Phase 2 InflammaSTOP Trial
NCT07840456Pas encore en recrutementPhase 2
- Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
NCT07214779Recrutement en coursPhase 3
- A Clinical Trial of MK-2010 With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Solid Tumors (MK-2010)
NCT07785609Recrutement en coursPhase 2
- A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
NCT07318558Recrutement en coursPhase 3
- Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
NCT06401980Recrutement en coursPhase 2
- Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
NCT07100080Recrutement en coursPhase 2 · Phase 3
- Personalized Volume-deescalated Elective Nodal Irradiation in Oropharyngeal Head and Neck Squamous Cell Carcinoma
NCT06563362Recrutement en coursPhase 2
- A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
NCT07213804Recrutement en coursPhase 3
- A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
NCT05067283Recrutement en coursPhase 1
- Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)
NCT07600749Recrutement en coursPhase 1
- A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
NCT07361497Recrutement en coursPhase 3
- Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
NCT06780670Recrutement en coursPhase 2 · Phase 3
- Visugromab in Cachexia International Trial
NCT07112196Recrutement en coursPhase 2 · Phase 3
- A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
NCT07023627Recrutement en coursPhase 2
- Safety and Early Signs of Efficacy of IL12-L19L19.
NCT04471987Recrutement en coursPhase 1
- Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer
NCT07002320Recrutement en coursPhase 1 · Phase 2
- Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
NCT06652438Recrutement en coursPhase 3
- Best Salvage Treatment for High-risk Relapsing Prostate Cancer (PEACE-9 - ESCALATE-RT)
NCT07782112Pas encore en recrutementPhase 3
- Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
NCT04221542Recrutement en coursPhase 1
- Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
NCT07106762Recrutement en coursPhase 2 · Phase 3
- A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
NCT05836324Recrutement en coursPhase 1
- Liquid Biopsy in Mature B-cell Tumors
NCT03280394Recrutement en cours
- Effect of a Music Intervention in Reducing Distress and Pain in Patients With Lung Cancer Undergoing Mini-invasive Surgery
NCT07235098Recrutement en cours
- A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
NCT05131022Recrutement en coursPhase 1
- Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma
NCT05700149Recrutement en cours
- Characterization of Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL) by Multiomic Approach
NCT07147751Pas encore en recrutement
- 177Lu-DOTATATE for Recurrent Meningioma
NCT06326190Recrutement en coursPhase 2
- Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
NCT05904119Recrutement en coursPhase 3
- Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer
NCT05815927Recrutement en coursPhase 3
- A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
NCT05384626Recrutement en coursPhase 1 · Phase 2
- A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.
NCT06284317Recrutement en coursPhase 3
- Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland
NCT03124212Recrutement en cours
- A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours
NCT06725758Recrutement en coursPhase 1 · Phase 2
- International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
NCT04043494Recrutement en coursPhase 3
- ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
NCT04916613Recrutement en coursPhase 3
- Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients
NCT06114108Recrutement en cours
- Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients.
NCT07481890Recrutement en cours
- Integrated Molecular and Clinical Profiling of Transformed Splenic Marginal Zone Lymphoma
NCT06712459Recrutement en cours
- Feasibility of Total Neoadjuvant Treatment With HYPErthermia in Patients With High-risk Extremity and Trunk Soft Tissue Sarcoma (TNT-HYPE)
NCT06835049Recrutement en coursPhase 2
- Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
NCT03567889Recrutement en coursPhase 3
- Combination Study of Antibiotics With Enzalutamide (PROMIZE)
NCT06126731Recrutement en coursPhase 1 · Phase 2
- Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer Patients
NCT03408964Recrutement en cours
- Tumor Molecular Profiling in Early Phase Clinical Trials
NCT04510766Recrutement en cours
- Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in Patients With Full-resected Early Breast Cancer
NCT04543799Recrutement en cours
- Metronidazole as Preoperative Therapy in CRC / FusoMetro-001
NCT05748145Recrutement en coursPhase 2
- Lifestyle Intervention in Patients With Metastatic Prostate Cancer
NCT05850182Recrutement en cours
- The Immune Landscape of Epithelial Ovarian Cancer
NCT05984875Recrutement en cours
- MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
NCT04111978Recrutement en coursPhase 3
- Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
NCT07075016Recrutement en coursPhase 3
- SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours
NCT05192980Recrutement en cours
- Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
NCT03643276Recrutement en coursPhase 3
- Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
NCT05017142Recrutement en cours
- FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
NCT04625907Recrutement en coursPhase 1 · Phase 2
- Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care
NCT04300257Recrutement en cours
- Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
NCT04045691Recrutement en cours